Melatonin was also shown to sensitize human hepatoma cells to ERS-induced apoptosis [88] and to decrease cell proliferation in the hepatocarcinoma HepG2 cell line via melatonin receptor 1, MT1RA, and decrease cAMP and ERK signaling [89]. This evidence concerns the gene MAPK1 and hepatocellular carcinoma.